Calcium channel blocking action of franidipine hydrochloride (CV-40932HCl) in vitro and in vivo.
スポンサーリンク
概要
- 論文の詳細を見る
The calcium-channel blocking action of franidipine (CV-4093·2HCl) was investigated in vitro and in vivo. CV-4093·2HCl inhibited the 60 mM K<SUP>+</SUP>-induced contraction of rabbit aorta and those of coronary, renal, mesenteric and femoral arteries of dog less potently than nifedipine and nicardipine. In dog portal and femoral veins, CV-4093·2HCl inhibited K<SUP>+</SUP>-induced contraction as potently as nifedipine and nicardipine did. The inhibitory effect of this drug was fully developed by pretreatment for 60 min, and it lasted long after washout. The drug inhibited both K<SUP>+</SUP>-induced <SUP>45</SUP>Ca-influx and K<SUP>+</SUP>-induced contraction at a similar concentration range in rabbit aorta and dog portal vein, but had no effect on <SUP>45</SUP>Ca-efflux from either vessel. On the other hand, in the isolated, perfused kidneys and mesenteric vascular beds of SHR, CV-4093·2HCl inhibited K<SUP>+</SUP>-induced vasoconstriction more effectively than did nifedipine. Moreover, in pithed rats (i.v.) and ganglion-blocked conscious SHR (p.o.), CV-4093·2HCl inhibited more potently α<SUB>2</SUB>-adrenergic pressor responses than did nicardipine. These pharmacological properties of CV-4093·2HCl, especially those seen in the isolated, perfused kidney and mesenteric vascular beds, may be responsible for its potent and long-lasting action as an antihypertensive agent.
- 公益社団法人 日本薬理学会の論文
著者
-
NISHIKAWA Kohei
Biological Research Laboratories, Central Research Division, Takeda Chemical Industries, Ltd.
-
KITOH Go
Biology Laboratories, Central Research Division, Takeda Chemical Industries, Ltd.
-
SHIBOUTA Yumiko
Biology Laboratories, Central Research Division, Takeda Chemical Industries, Ltd.
-
KITAYOSHI Takahito
Biology Laboratories, Central Research Division, Takeda Chemical Industries, Ltd.
関連論文
- Inhibition of Angiotensin Converting Enzyme by CV-3317 a Non-Sulfhydryl Compound
- INVOLVEMENT OF ADRENERGIC MECHANISM IN THE DIURETIC ACTION OF o-CHLOROBENZYL METHYL SULFOXIDE (DS-30) IN THE RAT
- Antagonistic action of AA-2414 on thromboxane A2/prostaglandin endoperoxide receptor in platelets and blood vessels.
- (R)-3-((S)-1-carboxy-5-(4-piperidyl)pentyl)amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-5-acetic acid (CV-5975): A new potent and long-lasting inhibitor of angiotensin converting enzyme.
- Calcium channel blocking action of franidipine hydrochloride (CV-40932HCl) in vitro and in vivo.
- Antihypertensive action of a new angiotensin converting enzyme inhibitor, (R)-3-((S)-1-carboxy-5-(4-piperidyl)pentyl)amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-5-acetic acid (CV-5975), in various hypertensive models.
- Antihypertensive action of a non-sulfhydryl angiotensin converting enzyme inhibitor (CV-3317) in various hypertensive models.